At first sight the question may seem to be a rhetorical one -we are so accustomed to look upon these two disciplines as complimentary for the assessment of hazard or risk that they appear to us to be closely interlinkedbut on reflection one could ask why should there be a meeting ground? The two disciplines are so very different. In epidemiological studies, the species investigated is the definitive species (man) and the conditions of exposure to the chemical, although often difficult to define, are real environmental ones both in terms of dose and in terms ofroute of exposure. In experimental toxicology, test and control groups are clearly defined and routes of treatment and dose levels well established, but the species used differ substantially from man in their physiology, anatomy, pharmacodynamics and metabolism. In fact, to many people, experimental toxicology is only suited for making the world a safer place for rats! And yet despite these difficulties and reservations, there are many situations where findings from experimental toxicology and epidemiology, complement one another to the advantage of mankind.
Animal models -useful when available
A few examples will illustrate this point. Soon after World War II cases were being reported of paresis and paralysis among workers using certain glues and varnishes. These reports originated first in Japan, and were followed by others from several countries. These reports led to a number of epidemiological studies which confirmed that there was an occupational association between the use of certain glues and varnishes and the disease'.
At first, it was difficult to link the paralysis to any definitive chemical but suspicion soon fell on n-hexane, which had been introduced on a large scale in certain industries. Intensive laboratory investigation soon established that n-hexane produced a peripheral neuropathy in animals similar to that found in humans and some indications of the mechanism of the nerve damage has been obtained from the animal studies. Thus, it is now known that there is the formation of a tangle of 10 nm fibres in the affected nerve which interferes with the flow of cytoplasm up and down the axon. This interference is seemingly due to a blockage of the cytoplasmic flow at the nodes of Ranvier. Laboratory studies have also identified the proximate metabolite responsible for the nerve lesion and in doing so demonstrated that a much less frequently used solvent, methylbutyl ketone (MBK) is also responsible for nerve paralysisl-'. This is a clear instance where experimental toxicology has helped to unravel the connection between occupational exposure to n-hexane and a serious occupational disorder identified epidemiologically.
Vinyl chloride evC) provided another instance where experimental toxicology was of some help in making a link between the type of cancer induced and a putative reactive metabolite. The first indication that VC was potentially dangerous came from the clinical observations of acroosteolysis (a bone disease affecting mainly the hands) in workers exposed to VC. This disease was recorded after several years of the use of VC in the plastics industry. Toxicologists recognized the need for investigating the safety of VC because of the reports of acroosteolysis and a study was conducted by Viola on the long-term effects of VC exposure. Tumours were produced in this study. It was followed by a large scale investigation to confirm this issue. A dose-related incidence of haemangiosarcomata were observed in this experiment. Almost simultaneously, similar tumours were reported in workers who had a repeated high level exposure to VC from cleaning the huge vats used for polymerization ofVC in the production of PVC. The very close similarity of the tumours found in man and rat provided experimental toxicologists with a model for further studies. The early histological lesions were characterized by Popper, and Gehring carried out some excellent studies on the metabolism of VC both at high levels which led to tumour production and at low levels of about 1 ppm or thereabouts which was the average exposure level of men working in a PVC manufacturing plant. Results showed that the metabolism of VC at high levels was very different from that at low levels -potentially reactive metabolites were identified at the higher concentrations while the metabolic products identified at low exposures were all thought to represent a detoxification reaction. At that time, (approximately 15 years ago), there was a considerable debate on whether VC should not be banned altogether because of the hazard it represented to workers and to those who lived close to VC manufacturing plants. The metabolic data provided a sufficient degree of reassurance for those concerned in the decision-making process to establish 1 ppm as providing a 'de minimis' risk and VC was not pushed off the industrial scene altogether. Of course, there were other reasons in favour of keeping VC (for example, its great economic importance) but, in my view, the contributions of experimental toxicology were of value in aiding the decision-making process", Other examples of a happy cooperation of this sort exist but the relationship between epidemiology and experimental toxicology is not always so productive. Difficulties experienced in the absence of animal models Let us now look at another situation where the epidemiologist came up with a positive result but the experimental toxicologist had failed to come up with a model. Benzene would serve-as an example. At one time, benzene was used extensively as an industrial solvent and a relatively high incidence of leukaemia was reported among workmen exposed to high levels of benzene (150 ppm and over). There are a number of such reports which, to my mind, leave little doubt that a cause and effect relationship exists between benzene exposure and an excess incidence of leukaemia. When experimental animals were exposed to benzene, no leukaemia was induced in either rats or mice -not convincingly at least. This failure cannot be explained on the basis that laboratory rodents are refractory to the development of this disease since leukaemia occurs naturally in these species and can be readily induced by ionising radiation. There is a further complicating factor. Benzene is also a bonemarrow poison and interferes with the production of blood cells, particularly the white cells. The myelotoxic effect occurs not only in man but also in laboratory animals particularly in mice so that it is even more difficult to understand why these rodents are seemingly totally resistant to the development of leukaemia from benzene".
Yet another example is the current concern generated by the epidemiological studies carried out on occupational groups exposed to solvents. Several such epidemiological studies have been carried out and most of them show some excess of individuals with a slight impairment of mental faculties in certain occupational groups exposed to solvents, particularly in painters -hence the name 'painters' syndrome'. The epidemiological studies carried out had several deficiencies and the conclusions drawn from these studies have been questioned. Yet they all appear to point in the same direction, namely that some intellectual or personality deficit exists in persons exposed to low levels of solvent vapour. This presents occupational physicians with a serious dilemma. Ifthe findings are true, then they would need to take energetic steps to deal with the situation, but the quality of the studies conducted does not inspire much confidence so that many occupational physicians do not feel justified in embarking on expensive programmes of prevention. Unfortunately, behavioural studies in animals have not been found suitable for investigating the so-called painters' syndrome and the current experimental attempts at analysing levels of neurotransmitters (and other chemicals in the brain thought to be implicated in eNS function) are not likely to yield any useful information. In the absence of a suitable model there would appear no way for resolving the dilemma that the epidemiological studies on solvent exposed workers have posed for occupational health workers-,
The episode of the 'toxic oil syndrome' in Spain provides another example of the difficulty experienced when no animal model is available to study the toxic effects in detail. The connection between the toxic oil and a serious illness which claimed hundreds of deaths is in no doubt, but despite this clear cause/effect relationship we are still ignorant of the nature of the chemical which caused such havoc. Whether this is because the offending oil was destroyed so that it was never available to experimentalists or because the Journal of the Royal Society of Medicine Volume 82 August 1989 471 laboratory animals are refractory to the effect of the toxic agent is immaterial -there is no animal model on which the toxicologistscan go to work. This episode serves to emphasize the need for animal models in order to arrive at the root of a toxicological problem posed by epidemiologists".
Indirect assistance from animal models The experimentalist may help in an indirect way. An example of this type of support for epidemiological findings is the extensive research done on the carcinogenicity of cigarette smoke condensate. The epidemiologist established beyond any reasonable doubt that cigarette smoking increases the risk for the development of pulmonary cancer in man. The experimentalist was unable to repeat these findings. Rats and mice are obligatory nose-breathers while man is not, so that the concentration of the smoke in the lung may not reach the same concentration as in man. Even with greater sophistication for the generation of cigarette smoke by the use of specialized machines no one has yet succeeded in producing in rats or mice the same type of pulmonary tumours that develop in man from cigarette smoke, although carcinoma ofthe larynx has been produced in hamsters. But scientists developed a different model -they obtained a kind of tar from cigarette smoke by condensing it and then painted this tar, suitably diluted, on the shaved skin of mice. A very large crop of tumours was produced in a dose-related manner which appeared to confirm the findings of the epidemiologists", There is a lesson here for those who insist that the route of exposure must be the same as in man ifthe experimental model is to be of relevance. Perhaps a bit oflateral thinking in developing such models is not out of place but this has its pitfalls! I think these examples suffice to indicate that experimental toxicology can be of great assistance in defining mechanisms of action thereby helping to establish the risk or the hazard on some acceptable scientific basis. Where animal models are lacking considerable uncertainty exists on the level of risk for man.
Predictive value of animal studies -need for caution In many instances, experimental models are often employed in order to 'predict' a potential hazard from a new chemical or in the diligent search for a hazard from a chemical that is widely used but is as yet untested. It is customary in these investigations to employ very high levels and prolongedadministration. Under these conditions it is not surprising that epidemiological results often fail to support the predictions from animal results.
One of the clearest and most recent example of this sort of situation is the mini saga on formaldehyde. This compound had been in use for several years as a laboratory fixative, an embalming agent and also industrially in the formation of several manmade polymeric materials'', It had been known for as long as formaldehyde has been in use that it irritated the nasal mucosa -anyone who entered a histology laboratory 10-11 years ago is well aware of this, but somehow, one got used to it. More seriously, it induced allergic phenomena in both the upper respiratory tract and in skin. In some individuals it also produced asthma. Thus, the adverse effects offormaldehyde were known and some measures were taken to reduce exposureand to remove susceptible individuals from exposure to its fumes. No further thought was given to the hazards from formaldehyde exposure until the Chemical Industry Institute of Toxicology carried out a carcinogenicity test by inhalation route, the one by which formaldehyde usually comes into contact with man. The concentration chosen was, however, about 7-15 times that inhaled by man and the duration (5 h/day, 5 days/ week for 108 weeks) was quite substantial and greater than any human would willingly endure. It was with some surprise that we first learnt that tumours were developing in the nasal cavity of treated rats and this surprise was still greater when news came through that all the rats treated with the highest dose (15 ppm) developed squamous cell carcinomas.
Because of the widespread use of formaldehyde (HCOH) this news caused great concern. Some epidemiological studies on the effects of exposure to HCOH had already been conducted and they were negative. The carcinogenicity results in rats led to several other studies on populations exposed to formaldehyde vapour, e.g, morticians, laboratory workers etc, but results were also negative.
Nevertheless, the suspicion and concern that HCOH may be carcinogenic to man continued, although they were considerably reduced in the face of epidemiological data.
The experimentalists then set about to answer the question they themselves had posed. They showed that at the levels which produced tumours, severe damage occurred in the mucosa of the rat resulting in squamous metaplasia and a high turnover of these cells. They further showed that at concentration levels of 1-3 ppm -the sort of levels to which man is likely to be exposed -the mucosa did not appear to be damaged even by using sensitive methods to detect it. In addition, it was shown biochemically that the mechanism for the detoxification of HCOH was adequate to prevent any tissue damage from these low concentrations of formaldehyde with which man comes into contact".
To my mind, the evidence from epidemiology is quite clear that at 1-3 ppm there is virtually no risk for the development of cancer by formaldehyde in man but, of course, this is negative evidence and is not fully convincing. The pathological and biochemical evidence from tests designed to understand the reason for the tissue damage give good scientific support to the epidemiological findings.
This mini saga is not at an end because there are still some who believe that the positive results in the rat are the dominant factor to be taken into account and overrides the epidemiology but there is always some hope that common sense may prevail.
This kind of frustrating experience in the interrelationship between epidemiology and experimental toxicology is illustrated also by the story of the carcinogenicity of saccharine. Saccharine was introduced as an artificial sweetener about 90 years ago when it was found that dietary carbohydrate restriction was an important means for the control of diabetes. Despite its use in many countries there was never any hint of an increase in bladder tumours in diabetics. Nevertheless, when cyclamate was introduced as an artificial sweetener and was found to complement saccharine it was thought that the marketable saccharine/cyclamate combination needed to be tested for carcinogenicity in rats. Cyclamate itself had been tested in several long-term tests in rats with a negative result but the combination was found to be carcinogenic. A fairly high incidence of tumours ofthe bladder were found in the treated rats. At first the culprit was thought to be the cyclamate but several studies were carried out on saccharine itself and in some experiments, where it was given at a dosage level which was 700 or 1000 times that of the human intake, bladder tumours were produced. This led many to interpret these findings as indicative of carcinogenic risk and there was considerable pressure on the authorities to ban saccharine without ceremony just as cyclamates were unceremoniously banned when the original carcinogenicity study of saccharine/cyclamate combination was found to be carcinogenic to the rat bladder. However, wiser counsels prevailed and a call for epidemiological evidence on the carcinogenicity of saccharine was made. Several studies have been carried out and these were in the main, negative. Saccharine, fortunately for the weight watchers and diabetics, is still with us and seems to be holding its own against the newer sweeteners. Thus, in the last two examples, the experimental toxicologist drew a red herring which sent epidemiologists scurrying on a false trail".
Another example where experimental toxicology identified a hazard which was not supported by epidemiology is the episode of dioxin toxicity. This chemical is a contaminant of phenoxyacetic acid herbicides. After the public outcry against these types of herbicides following their extensive use in Vietnam as defoliating agents they were subjected to extensive studies in animals. They were found to be both highly toxic and carcinogenic as well as teratogenic. This activity was soon traced to a contaminant -dioxin. Following this discovery several epidemiological studies were carried out. The ones carried out on employees were inconclusive. The studies carried out on Vietnam veterans who had a high exposure to commercial phenoxyacetic acids containing dioxin were not any more informative. And yet the animal evidence was so convincingly positive that the failure of epidemiological studies to provide a positive answer was attributed to the poor quality of the studies. Then came an explosion in a chemical factory near Seveso a town in North Italy where there was a fairly heavy human exposure to dioxin, although a brief one. There was considerable concern because it was thought that this high exposure would result in many deaths and, fetal malformations. Fortunately, these ominous fears were unfulfilled since apart from chloracne there was no unusual incidence of any other type of disease. Perhaps it would have been better if the experiments had not been carried out -a considerable number of people at Seveso would have been spared a great deal of anguish and apprehension'".
Pitfalls from inappropriate animal experiments
Lastly I would like to draw your attention to the difficulties experimental toxicologists lead themselves into when inappropriate experimental tests are employed and not only confuse themselves but confuse the epidemiologists as well. The example I like to quote is nickel.
Some early epidemiological studies of workers in nickel refineries demonstrated clearly that there was an excess incidence of cancers of the nasal cavity and lung in this group of people. This was later confirmed by further epidemiological studies which not only implicated refineries but also other processes such as roasting and electrolysis. The chemists identified a wide array of inorganic nickel compounds as well as nickel metal in the fumes inhaled by workers at these factories and a whole series of nickel compounds were investigated experimentally. At the time these early epidemiological results were being published there was one simple and, according to many, a reliable way of testing for carcinogenic activity -namely administration by the subcutaneous or intramascular route. Virtually all nickel compounds that were found in nickel processing plants were tested by this route and all produced sarcomas. The results of the subcutaneous route of administration were then taken to indicate a significant carcinogenic risk and nickel and all its salts were labelled as 'carcinogenic' in animals and potentially carcinogenic for man. The implication from experimental toxicology was that the nickel in prosthetic implants or in the 'coin in your pocket', to borrow a phrase, was potentially carcinogenic. To me it is surprising that these experimental results attracted little attention and that there was no outright ban on nickel. Perhaps it is as well that such drastic measures were not taken because subsequent experience with the subcutaneous and intramuscular route revealed that these routes are most unreliable as indices of carcinogenicity. The entire problem of nickel carcinogenicity is now being re-investigated toxicologically by more appropriate routes!'. This episode shows quite clearly how the experimental toxicologist can mislead himself and others by producing false data which, because of their emotive implications, are difficult to be placed in a proper scientific perspective.
I have tried to answer the question -Is there meeting ground between epidemiology and experimental toxicology? I have tried to indicate that the answer to this question is probably a guarded 'yes'. The meeting ground, however, is not smooth and uniform. It is quite firm in some instances, and where this occurs, the findings from epidemiology can be considerably strengthened and some light is thrown on the mechanism of action. Under these circumstances, it is possible to arrive at a rational appraisal of hazard or risk.
There are situations where experimental toxicology falls short of providing a model for testing the Journal of the Royal Society of Medicine Volume 82 August 1989 473 hypothesis generated by epidemiological studies and, in these instances, the absence of a meeting ground leaves a gap in our understanding of the problem outlined in the hypothesis.
There are other situations where experimental toxicology suggests the existence of a hazard which is not confirmed by epidemiological findings. This may bedue either to the use ofvery high doses which induce considerable alteration in organ function or to an inappropriate route for testing the material.
I would like to conclude by saying that, although most of our work in experimental toxicology may well be only relevant to make this planet safe for rats, some of it does have a direct relevance for man.
